YOD1 regulates oxidative damage of dopamine neurons in Parkinson's disease by deubiquitinating PKM2
Abstract Background Parkinson's disease (PD) is a common neurodegenerative movement disorder, mainly characterized by the degeneration and loss of dopaminergic neurons in the substantia nigra. Oxidative stress is considered to be a key contributor to dopaminergic neuronal degeneration, triggeri...
Saved in:
| Main Authors: | Xia Zhao, Jinfeng Sun, Fan Chen, Hao Tang, Yuqing Zeng, Luyao Li, Qin Yu, Linjie Chen, Muzaffar Hammad, Xiaoxia Xu, Ziyao Meng, Wei Wang, Guang Liang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Clinical and Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ctm2.70420 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AARS2 ameliorates myocardial ischemia via fine-tuning PKM2-mediated metabolism
by: Zongwang Zhang, et al.
Published: (2025-05-01) -
PKM2-driven metabolic reprogramming in digestive system tumors: mechanisms, therapeutic advances, and clinical challenges
by: Xinyao Huang, et al.
Published: (2025-08-01) -
Nuclear PKM2: a signal receiver, a gene programmer, and a metabolic modulator
by: Tsan-Jan Chen, et al.
Published: (2025-08-01) -
Novel targets for treating neurodegenerative diseases: The PKM2-STAT3-hnRNPA1 feedback loop
by: Ping Ye, et al.
Published: (2025-08-01) -
SULT2B1: a novel therapeutic target in colorectal cancer via modulation of AKT/PKM2-mediated glycolysis and proliferation
by: Jianxing Ma, et al.
Published: (2024-12-01)